These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8523936)

  • 1. [Agranulocytosis induced by calcium dobesilate].
    Cladera Serra A; Blasco Mascaró I; Oliva Berini E; Ramos Díaz F
    Med Clin (Barc); 1995 Oct; 105(14):558-9. PubMed ID: 8523936
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium dobesilate-induced agranulocytosis.
    Duggal L; Thukral R; Kumar S
    J Assoc Physicians India; 2005 Apr; 53():320-1. PubMed ID: 15987021
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium dobesilate-induced agranulocytosis.
    García Benayas E; García Díaz B; Pérez G
    Pharm World Sci; 1997 Oct; 19(5):251-2. PubMed ID: 9368927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of drug-induced agranulocytosis: the case of calcium dobesilate.
    Zapater P; Horga JF; García A
    Eur J Clin Pharmacol; 2003 Mar; 58(11):767-72. PubMed ID: 12634984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches.
    Ibáñez L; Ballarín E; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):763-7. PubMed ID: 11214789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
    Allain H; Ramelet AA; Polard E; Bentué-Ferrer D
    Drug Saf; 2004; 27(9):649-60. PubMed ID: 15230646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent agranulocytosis after taking calcium dobesilate].
    Kulessa W; Becker EW; Berg PA
    Dtsch Med Wochenschr; 1992 Mar; 117(10):372-4. PubMed ID: 1544335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk of drug-induced agranulocytosis: an approximation to risk analysis arising from spontaneous notification of agranulocytosis cases among patients treated with calcium dobesilate].
    Zapater Hernández P; Horga de la Parte JF; García AG
    An Med Interna; 2002 Jun; 19(6):275-82. PubMed ID: 12152385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium dobesilate: neutropenia.
    Prescrire Int; 2010 Oct; 19(109):218. PubMed ID: 21188809
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dobesilate-induced serious neutropenia].
    Burgan F; Montastruc JL; Bagheri H
    Presse Med; 2009 May; 38(5):846-8. PubMed ID: 19278816
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of calcium dobesilate in treating acute attacks of hemorrhoidal disease.
    Menteş BB; Görgül A; Tatlicioğlu E; Ayoğlu F; Unal S
    Dis Colon Rectum; 2001 Oct; 44(10):1489-95. PubMed ID: 11598479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study with suppositories doxiproct and doxiproct plus in the treatment of hemorrhoids (author's transl)].
    Wissmer B
    Schweiz Rundsch Med Prax; 1975 Oct; 64(40):1295-6. PubMed ID: 1219707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness and innocuousness of the association of calcium dobesilate, dexamethasone acetate and lidocaine versus prednisolone capronate with dibucaine clorohydrate in the treatment of hemorrhoids-].
    Marsicano LJ; Pérez M; Urquiola G
    G E N; 1995; 49(4):296-302. PubMed ID: 8762660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local treatment of acute hemorrhoidal crises (author's transl)].
    Berson I
    Schweiz Rundsch Med Prax; 1975 Mar; 64(10):299-301. PubMed ID: 1215272
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
    Flota-Cervera F; Flota-Ruiz C; Treviño C; Berber A
    Angiology; 2008; 59(3):352-6. PubMed ID: 18388097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of calcium dobesilate in the treatment of cerebral circulatory insufficiency. Apropos of 30 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Oct; 19(8 Suppl 3):886-9. PubMed ID: 4618592
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug fever attributable to Calcium Dobesilate.
    Galindo Bonilla PA; García Rodríguez R; Feo Brito F; Encinas Barrios C; G-omez Torrijos E; Fernández Martínez F
    Allergol Immunopathol (Madr); 1996; 24(1):19-21. PubMed ID: 8882756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced fever: a clinical report and challenge test with calcium dobesilate.
    Puyana J; Fraj J; De La Hoz F; Davila I; Vergara C; Cuesta J
    Int Arch Allergy Appl Immunol; 1990; 92(4):364-5. PubMed ID: 2083972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dobesilate Calcium in the treatment of chronic kidney failure].
    Liu XC; Lu YM; Jin XB; Zeng HB; Gao HY
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1892-3. PubMed ID: 15631801
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.